Skip to main content ( press enter )

Search

Reset filter
Displaying results 582 - 588 of 1159
Dozens of Peter Mac researchers feature in Stanford University’s worldwide highly-cited list
An impressive fifty-five Peter Mac researchers have been named in the top two per cent of most-cited scientists in the world based on a recently updated study published by Stanford... Read more
New study seeks to revolutionise personalised treatment for lung cancer 
  The ASPiRATION-2 Liquid study has been awarded $14.7 million in funding through a Medical Research Future Fund (MRFF) Frontier Grant. Researchers from Peter Mac will collaborate with colleagues across Australia to... Read more
Variants in Practice (ViP)
The ViP (Variants in Practice) study is a clinic-based cohort of high-risk breast and ovarian cancer families.Our goal is to offer participation in ongoing genomic research to all families undergoing assessment and genetic... Read more
Comprehensive genomic testing aids precision therapy and tissue of origin identification for CUP patients
A new study published in Nature Communications highlights the potential of whole genome and transcriptome sequencing (WGTS) to improve precision treatment and identify tissue of origin for cancers of unknown primary (CUP). The... Read more
Breast Cancer Survivorship Program and shared care
The model of care involves patients and their GPs (General Practitioners). It recognises the specific issues and opportunities at the end of active breast cancer treatment. And its aim is to support survivors to live... Read more
SUPER-ED: Solving Unknown Primary cancER Earlier Diagnosis
People with Cancer of Unknown Primary (CUP) have a poor prognosis and may undergo a protracted diagnostic workup causing patient distress and high cancer related costs. Not having a primary diagnosis limits timely site-specific... Read more
Back to top